Recall
FDAHealthMarch 12, 2026

Beta Bionics, Inc. — iLet Bionic Pancreas, REF: BB1001

⚠️ insulin pump software versions 1.4.2, and 1.4.3 issue with Dexcom Continuous Glucose Monitoring (CGM) G7 sensor may result in delayed CGM reading then switch to non-CGM dosing, leading to only basal/requested meal doses provided, no correction doses/insulin reductions/suspensions for high/low glucose unless blood glucose entered for sensor life or replacement. Potential health risks to users include severe hyperglycemia with and without DKA and severe hypoglycemia.

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
March 12, 2026

US Nationwide distribution in the states of TX, PA, AL, MI, OH, FL, TN, GA.

What's affected?

Product
iLet Bionic Pancreas, REF: BB1001
Lot code
Software versions 1.4.3, and 1.4.2

Additional details

Software versions 1.4.3, and 1.4.2

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 1,080.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.